1)板垣 隆・宇山昌延:卵黄状黄斑変性の臨床像.臨眼 37:343-349,1983
2)湯澤美都子:卵黄様黄斑ジストロフィ.眼科 26:1089-1100,1984
3)近藤峰生・近藤永子・谷川篤宏・他:卵黄状黄斑変性症6例の検討.眼臨 91:313-317,1997
4)柳田 泰・小沢博子・高橋 修:網膜下出血を合併した卵黄様黄斑変性の1例.眼紀 34:1924-1929,1983
5)佐藤ひとみ・柳田 泰:卵黄様黄斑変性は脈絡膜新生血管を高頻度に合併するか? 臨眼 45:937-940,1991
6)Fishman GA, Baca W, Alexander KR et al:Visual acuity in patients with Best vitelliform macular dystrophy. Ophthalmology 100:1665-1670, 1993
7)Andrade RE, Farah ME, Costa RA:Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease. Am J Ophthalmol 136:1179-1181, 2003
8)Ergun E, Costa D, Slakter J et al:Photodynamic therapy and vitelliform lesions. Retina 24:399-406, 2004
9)Viola F, Villani E, Mapelli C et al:Bilateral juvenile choroidal neovascularization associated with Best's vitelliform dystrophy:observation versus photodynamic therapy. J Pediatr Ophthalmol Strabismus 47:121-122, 2010
10)Leu J, Schrage NF, Degenring RF:Choroidal neovascularisation secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol 245:1723-1725, 2007
11)Rishi E, Rishi P, Mahajan S:Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy. Indian J Ophthalmol 58:160-162, 2010
12)Mandal S, Sinha S, Venkatesh P et al:Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy. Indian J Ophthalmol 59:262-263, 2011
13)Perol J, Wolff B, Sahel JA et al:Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease. J Fr Ophtalmol 34:281-286, 2011
14)Montero JA, Ruiz-Moreno JM, De La Vega C:Intravitreal bevacizumab for adult-onset vitelliform dystrophy:a case report. Eur J Ophthalmol 17:983-986, 2007
15)Lee JY, Lim J, Chung H et al:Spectral domain optical coherence tomography in a patient with adult-onset vitelliform dystrophy treated with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging 40:319-321, 2009
16)Iannaccone A, Kerr NC, Kinnick TR et al:Autosomal recessive best vitelliform macular dystrophy:report of a family and management of early-onset neovascular complications. Arch Ophthalmol 129:211-217, 2011